This inventor holds 3 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 1991-1993.
Company Filing History:
Years Active: 1991-1993
Title: Dale R Brinker: Innovator in Sustained-Release Drug Dosage Units
Introduction
Dale R Brinker is a notable inventor based in Antioch, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release drug dosage units. With a total of 3 patents to his name, Brinker continues to impact the medical community through his innovative work.
Latest Patents
Brinker's latest patents focus on sustained-release drug dosage units of terazosin. One of his patents describes a sustained-release coating composition that includes ethylcellulose and/or methacrylic methylester, along with a plasticizer and a detackifying agent. This composition is used to coat sized drug granules, which are then mixed with a polymeric composition containing at least one viscosity agent. The resulting drug dosage units are designed for the administration and sustained release of the drug in patients. These units provide a continuous, slow release of the drug at a therapeutically effective dosage level.
Career Highlights
Dale R Brinker is associated with Abbott Laboratories Corporation, where he applies his expertise in drug formulation and development. His work has been instrumental in advancing the effectiveness of drug delivery systems, particularly in the area of sustained-release medications.
Collaborations
Brinker has collaborated with notable colleagues, including Enrique D Eveline and Thomas L Reiland. These partnerships have contributed to the successful development of innovative pharmaceutical solutions.
Conclusion
Dale R Brinker is a distinguished inventor whose work in sustained-release drug dosage units has made a significant impact on the pharmaceutical industry. His contributions continue to enhance patient care through improved drug delivery methods.